Scout | NCI ETCTN Pharmacokinetics Resource Laboratory (U24) to Support Early-Phase Cancer Drug Trials

This opportunity is no longer accepting applications.

nofo

NCI ETCTN Pharmacokinetics Resource Laboratory (U24) to Support Early-Phase Cancer Drug Trials

The National Cancer Institute is seeking U24 applications to create or maintain a Pharmacokinetics (PK) Resource Laboratory for its Experimental Therapeutics Clinical Trials Network (ETCTN). The lab will coordinate biospecimen collection and perform analyses of pharmacokinetics, drug-drug and CYP interactions, pharmacodynamics, and food effects for NCI investigational drugs in early-phase IND-…

Source

Agency: National Institutes of Health

Award

Total Funding: $850,000

Eligibility

small_business

nonprofit

university

For profit organizations other than small businesses

Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education

Private institutions of higher education

Keywords

pharmacokinetics

clinical trials

cyp interactions

biospecimen collection

drug-drug interactions

early phase oncology

u24 grant

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers